Aptus Pharma Limited (BOM:544529)

Aptus Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	18.02	10.27	52.14	9.14	5.37	2.61
Cash & Short-Term Investments	18.02	10.27	52.14	9.14	5.37	2.61
Cash Growth	-87.38%	-80.30%	470.20%	70.41%	105.97%	249.19%
Accounts Receivable	286.42	187.6	56.39	33.54	23.98	18.5
Receivables	319.04	189.49	59.3	37.82	27.65	18.86
Inventory	162.53	135.69	70.58	34.26	22.99	13.94
Prepaid Expenses	-	0.44	1.31	0.37	0.23	0.2
Other Current Assets	-0	16.47	14.03	1.63	0.29	0.65
Total Current Assets	499.58	352.36	197.36	83.22	56.52	36.25
Property, Plant & Equipment	31.25	26.94	9.63	6.17	5.14	3.47
Long-Term Investments	-	-	-	10.06	-	-
Other Intangible Assets	0.54	0.75	0.28	0	0	0
Long-Term Deferred Tax Assets	1.01	0.92	0.74	0.56	0.36	0.19
Other Long-Term Assets	13.16	54.38	11.2	0.09	0.09	0.09
Total Assets	545.54	435.35	219.2	100.1	62.11	40

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	91.36	81.53	13.09	18.45	25.78	9.11
Accrued Expenses	-	14.07	11.9	2.63	1.51	0.32
Short-Term Debt	-	64.47	66.37	9.91	-	-
Current Portion of Long-Term Debt	50.68	2.13	11	3.57	2.05	1.92
Current Income Taxes Payable	-	17.02	11.17	3.14	1.05	0.51
Other Current Liabilities	45.23	13.84	7.31	3.26	0.7	8.96
Total Current Liabilities	187.28	193.06	120.84	40.97	31.09	20.81
Long-Term Debt	70.43	5.22	26.2	39.6	20.07	10.67
Pension & Post-Retirement Benefits	3.61	3.61	2.5	-	-	-
Total Liabilities	261.32	201.89	149.54	80.56	51.16	31.48

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	171.5	68.6	50	3	3	3
Additional Paid-In Capital	-	107	8	3.5	3.5	-
Retained Earnings	-	57.86	11.66	13.04	4.44	5.52
Shareholders' Equity	284.23	233.46	69.66	19.54	10.94	8.52
Total Liabilities & Equity	545.54	435.35	219.2	100.1	62.11	40

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	121.11	71.82	103.57	53.08	22.12	12.58
Net Cash (Debt)	-103.09	-61.55	-51.43	-43.94	-16.75	-9.98
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.05	-4.15	-4.23	-11.71	-9.17	-5.46
Filing Date Shares Outstanding	17.15	17.15	12.5	3.75	3.75	3.75
Total Common Shares Outstanding	17.15	17.15	12.5	3.75	3.75	3.75
Working Capital	312.31	159.3	76.53	42.26	25.43	15.44
Book Value Per Share	16.57	13.61	5.57	5.21	2.92	2.27
Tangible Book Value	283.68	232.71	69.39	19.54	10.94	8.51
Tangible Book Value Per Share	16.54	13.57	5.55	5.21	2.92	2.27
Buildings	-	10.31	0.88	-	-	-
Machinery	-	29.15	17.34	12.15	8.99	5.52

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error